参考文献/References:
[1]Feng L,Hua C,Sun H,et al.Association between Serum Uric Acid Level and Carotid Atherosclerosis in Chinese Individuals Aged 75 Years or Older: A Hospital-Based Case-Control Study[J].Journal of Nutrition Health & Aging,2018,22(4):508-512.[2]陶鹏辉.老年高血压患者血清同型半胱氨酸、超敏C反应蛋白及胱抑素C水平与颈动脉内膜中层厚度的相关性分析[J].新乡医学院学报,2017,34(5):416-418,422.[3]曹明,王奇军.H型高血压患者血浆同型半胱氨酸水平变化对动脉粥样硬化性疾病的影响[J].检验医学,2019,34(11):1007-1010.[4]高峰利,韩涛,张维,等.血压变异性与急性脑梗死合并H型高血压患者脑梗死严重程度及颈动脉内膜中膜厚度的关系研究[J].实用心脑肺血管病杂志,2017,25(8):45-48.[5]董海燕,章艳,吕莉丽,等.高压氧治疗对急性脑梗死合并颈动脉粥样硬化斑块患者认知功能及血清同型半胱氨酸水平的影响[J].中华航海医学与高气压医学杂志,2020,27(1):92-94.[6]贾军,黄亮,张占华.急性脑梗死患者血清亲环素A、单核细胞趋化蛋白1水平与颈动脉粥样硬化的相关性研究[J].海南医学院学报,2017,23(11):1579-1581,1585.[7]Doliner BB,Dong C,Blanton SH,et al.Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study - ScienceDirect[J].Journal of Stroke and Cerebrovascular Diseases,2018,27(3):645-652.[8]梁志刚,孙旭文,杨绍婉,等.伴有颈动脉斑块的急性缺血性卒中患者急性期血清学相关指标水平的研究[J].临床神经病学杂志,2018,31(6):425-428.[9]高华,李沛珊,裴静,等.基质金属蛋白酶9和胱抑素C水平与急性脑梗死患者颈动脉粥样硬化斑块稳定性的关系研究[J].实用心脑肺血管病杂志,2018,26(1):34-37.[10]徐浩,章鸯,唐彪,等.2型糖尿病患者发生颈动脉粥样硬化的危险因素分析[J].中国卫生检验杂志,2019,29(4):494-496.[11]张军,张琦,吴艳艳,等.半乳糖凝集素3与2型糖尿病患者颈动脉粥样硬化相关性的研究[J].中国糖尿病杂志,2020,28(3):197-201.[12]朱海锋,成兴波.2型糖尿病合并颈动脉粥样硬化患者血清丝氨酸蛋白酶抑制剂B1水平变化的研究[J].中国糖尿病杂志,2020,28(4):22-25.[13]郭璐映,刘儒,张保朝.单纯舒张期高血压患者舒张压峰值与颈动脉粥样硬化的相关性[J].新乡医学院学报,2018,35(4):320-322.[14]徐蓓峥,俞建康,黄新梅,等.社区中老年人群颈动脉粥样硬化与血浆致动脉粥样硬化指数的关系及其危险因素研究[J].中华全科医学,2019,17(1):109-112.[15]刘红,王引利,郭良敏,等.高海拔贫困地区动脉粥样硬化患者血尿酸水平与饮食习惯的相关性分析[J].成都医学院学报,2019,14(6):769-772,777.[16]吴湘军,郑海燕,朱亚兰.血清同型半胱氨酸、尿酸、超敏C反应蛋白水平与腔隙性脑梗死患者颈动脉粥样硬化程度的关系探讨[J].实用医院临床杂志,2020,17(2):220-223.[17]顾汉沛,葛剑青,王光胜.血浆Lp-PLA2、HCY、尿酸与血脂对稳定大动脉粥样硬化性脑梗死病人颈动脉斑块的临床意义[J].中西医结合心脑血管病杂志,2017,15(5):613-616.[18]张蕊,陈海兰,秦诗阳,等.2型糖尿病患者血浆同型半胱氨酸水平与颈动脉粥样硬化患者颈动脉内-中膜厚度的相关性研究[J].临床和实验医学杂志,2019,18(10):1058-1061.[19]王庆,田海涛,王鸿燕,等.血清同型半胱氨酸及超敏C反应蛋白水平与老年原发性高血压患者颈动脉粥样硬化程度的关系研究[J].现代生物医学进展,2020,20(3):484-487.[20]葛君,汪朝晖,宣玲.高血压患者血清hs-CRP,Hcy及UA水平与颈动脉粥样硬化的相关性研究[J].中华全科医学,2019,17(7):75-78.[21]Golpe R,Mateos-Colino A,González-Juanatey C,et al.Subclinical Carotid Atherosclerosis in COPD Cases and Control Smokers: Analysis in Relation with COPD Exacerbations and Exacerbation-like Episodes[J].Lung,2017,195(2):185-191.
相似文献/References:
[1]戴 琦,郑建军,金银华,等.DWI联合双能量CTA研究急性腔隙性脑梗死与
颈部动脉粥样硬化的相关性[J].医学信息,2018,31(12):153.[doi:10.3969/j.issn.1006-1959.2018.12.049]
DAI Qi,ZHENG Jian-jun,JIN Yin-hua,et al.DWI Combined with Dual-energy CTA to Study the Relationship between Acute Lacunar Infarction and Carotid Atherosclerosis[J].Journal of Medical Information,2018,31(16):153.[doi:10.3969/j.issn.1006-1959.2018.12.049]
[2]倪 菁,白 丹,雷 飞,等.亚临床甲状腺功能减退对颈动脉粥样硬化和心功能的影响[J].医学信息,2018,31(14):49.[doi:10.3969/j.issn.1006-1959.2018.14.016]
NI Jing,BAI Dan,LEI Fei,et al.Effect of Subclinical Hypothyroidism on Carotid Atherosclerosis and Cardiac Function[J].Journal of Medical Information,2018,31(16):49.[doi:10.3969/j.issn.1006-1959.2018.14.016]
[3]欧德福.超声评价老年心血管病患者颈动脉粥样硬化的价值[J].医学信息,2018,31(23):158.[doi:10.3969/j.issn.1006-1959.2018.23.046]
Ou De-fu.Cardiovascular Disease[J].Journal of Medical Information,2018,31(16):158.[doi:10.3969/j.issn.1006-1959.2018.23.046]
[4]宫园园.LDL、Hcy、D-二聚体及颈动脉粥样硬化与急性缺血性脑卒中相关性研究[J].医学信息,2019,32(05):117.[doi:10.3969/j.issn.1006-1959.2019.05.036]
GONG Yuan-yuan.Correlation between LDL,Hcy,D-dimer and Carotid Atherosclerosis and Acute Ischemic Stroke[J].Journal of Medical Information,2019,32(16):117.[doi:10.3969/j.issn.1006-1959.2019.05.036]
[5]汪 艳,杨 俊,段会仙,等.糖耐量异常患者血清癌胚抗原相关细胞黏附分子1与
动脉粥样硬化的关系[J].医学信息,2019,32(18):55.[doi:10.3969/j.issn.1006-1959.2019.18.018]
WANG Yan,YANG Jun,DUAN Hui-xian,et al.Relationship between Serum Carcinoembryonic Antigen-associated Cell Adhesion Molecule-1 and Atherosclerosis in Patients with Impaired Glucose Tolerance[J].Journal of Medical Information,2019,32(16):55.[doi:10.3969/j.issn.1006-1959.2019.18.018]
[6]潘建鑫.高血压患者血小板/淋巴细胞比值与颈动脉粥样硬化的相关性分析[J].医学信息,2020,33(05):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
Pan Jianxin.Correlation analysis of platelet/lymphocyte ratio and carotid atherosclerosisin patients with primary hypertension[J].Journal of Medical Information,2020,33(16):77.[doi:10.3969/j.issn.1006-1959.2020.05.023]
[7]来佳成,韩永生.脂蛋白磷脂酶A2、非高密度胆固醇与颈动脉粥样硬化程度的相关性研究[J].医学信息,2021,34(09):115.[doi:10.3969/j.issn.1006-1959.2021.09.030]
LAI Jia-cheng,HAN Yong-sheng.Study on the Correlation Between Lipoprotein Phospholipase A2,Non-high-density Cholesterol and the Degree of Carotid Atherosclerosis[J].Journal of Medical Information,2021,34(16):115.[doi:10.3969/j.issn.1006-1959.2021.09.030]
[8]董瑞聪,张 驰,杨振梅,等.老年高血压患者血清TMAO水平与颈动脉粥样硬化的相关性研究[J].医学信息,2023,36(21):78.[doi:10.3969/j.issn.1006-1959.2023.21.017]
DONG Rui-cong,ZHANG Chi,YANG Zhen-mei,et al.Correlation Between Serum TMAO Level and Carotid Atherosclerosis in Elderly Patients with Hypertension[J].Journal of Medical Information,2023,36(16):78.[doi:10.3969/j.issn.1006-1959.2023.21.017]
[9]王学燕,汪媛媛,季明德.Lp-PLA2、Hcy、CRP、Lp(a)、AT-Ⅲ联合预测高血压患者颈动脉粥样硬化发生的风险[J].医学信息,2024,37(12):93.[doi:10.3969/j.issn.1006-1959.2024.12.020]
WANG Xue-yan,WANG Yuan-yuan,JI Ming-de.Value of Lp-PLA2, Hcy, CRP, Lp(a) and AT-Ⅲ in Predicting the Risk of Carotid Atherosclerosis in Patients with Hypertension[J].Journal of Medical Information,2024,37(16):93.[doi:10.3969/j.issn.1006-1959.2024.12.020]
[10]肖金燕,吴 娇,张柳金,等.颈动脉彩超评价原发性高血压患者颈动脉粥样硬化的临床价值[J].医学信息,2024,37(12):126.[doi:10.3969/j.issn.1006-1959.2024.12.028]
XIAO Jin-yan,WU Jiao,ZHANG Liu-jin,et al.Clinical Value of Carotid Artery Ultrasonography in Evaluating Carotid Atherosclerosis in Patients with Essential Hypertension[J].Journal of Medical Information,2024,37(16):126.[doi:10.3969/j.issn.1006-1959.2024.12.028]